from $199.99/mo
Microdose semaglutide
People comparing lower monthly cost, prior semaglutide response, nausea history, and weekly injection tolerance.
- Ingredient
- Semaglutide
- Receptor target
- GLP-1 receptor agonist
- Starting dose
- 0.25 mg once weekly
Tirzepatide • 1 mg weekly start
Microdose
tirzepatide
The dual GIP/GLP-1 medication behind Mounjaro and Zepbound, started lower and slower: 1 mg once weekly if prescribed, with appetite, nausea, and dose history deciding when — or whether — the dose moves.
1 mg Weekly StartDose Adjusted If NeededTolerance Checked
Start your online visitfrom$299.99/mo$199.99/moSave $100
FSA & HSA eligibleUse eligible benefit funds
Split your payment into interest-free installments with Klarna at checkout.
Dual GIP & GLP-1 receptor agonist
Weekly subcutaneous microdose
1 mg starting dose if prescribed
Charged today — ships if prescribed
Tirzepatide is prescription-only. A licensed provider reviews your health history before prescribing. Not for everyone; individual results vary.
Format:
Weekly injection
Weekly injection
1 mg weekly
start
start
Rx only
History
checked
checked
Follow-up
access
access
Why microdose
Start tirzepatide with a smaller first step.
Microdose tirzepatide is weekly GLP-1/GIP appetite care for people comparing a lower first dose, prior GLP-1 use, GI side effects, and monthly cost before choosing standard escalation.
01
Start below the usual label ramp
This option starts at 1 mg once weekly, below the 2.5 mg branded starting dose people often compare against.
02
Built for appetite review
Cravings, portions, blood-sugar history, and prior GLP-1 use all change the tirzepatide decision.
03
Side effects steer the next dose
Nausea, reflux, constipation, dehydration, medications, and dose history matter before holding or changing a weekly injection.
04
Appetite control should not cost you muscle
Protein, resistance training, dose tolerance, and weight trend belong in the same plan, especially when appetite drops.
The dose track
Start low. Do not climb on autopilot.
The first dose, any hold, and any dose change depend on appetite response, nausea or reflux, constipation, medications, dose history, and the prescription that is actually written.
Starting dose
1 mg weekly
1 mg
once weekly · if prescribed
Lower starting dose
Not a DIY chart
Your written directions set units and volume — not a forum chart.
Follow-up
Response check
Review
appetite and side effects, checked
Appetite trend
Side effects
No automatic week-by-week jump.
Dose decision
Hold or change
Rx
hold, change, or stop — per your Rx
Hold, change, or stop
Rx instructions
Not enough? Switching to standard GLP-1 care is on the table.
For reference, FDA-approved tirzepatide labeling starts at 2.5 mg weekly for 4 weeks, then 5 mg, with later 2.5 mg step changes when appropriate. This compounded 1 mg start is not the branded label schedule.
Science explainers
The science behind a lower-and-slower start.
Tirzepatide acts on GLP-1 and GIP receptors. The microdose difference is pace: start from 1 mg when prescribed, watch appetite and side effects, then hold or change the weekly dose only when needed.
2
Receptors engaged — GIP and GLP-1 — versus one for older agents.
~5d
Half-life that supports once-weekly dosing.
GLP-1 microdosing
Start with the GLP‑1 question, then choose the molecule.
Microdosing starts with the same practical review: appetite, prior use, medications, side-effect history, blood-sugar history, and whether you want a once-weekly injection.
from $199.99/mo
Microdose tirzepatide
People comparing dual-receptor tirzepatide, prior GLP-1 dose history, appetite goals, and GI side-effect history.
- Ingredient
- Tirzepatide
- Receptor target
- GLP-1 + GIP receptor agonist
- Starting dose
- 1 mg once weekly
Compounded GLP-1 microdosing schedules are not FDA-approved or FDA-reviewed for safety, effectiveness, or quality. A licensed provider must decide whether any prescription, dose, format, or refill is appropriate.
How tirzepatide works
Two gut hormones, one weekly dose.
GIPreceptorGLP-1
receptorAppetite
& glucoseDual agonist
Why slower wins
Appetite response without autopilot titration.
Week 1:1 mgHold if
nausea
Appetite, quieted
Fewer cravings. More room to choose.
SloweremptyingFuller,
longerSteadier
glucoseFewer
cravings
What's inside
Tirzepatide,
glycine & B12.
The pharmacy label lists the concentration of tirzepatide, glycine, and B12, along with syringe units and the prescribed weekly amount.
Active
Tirzepatide (GIP/GLP-1 receptor agonist)
Compounded with
Glycine and B12; exact concentrations appear on the pharmacy label
Starting dose
1 mg once weekly if prescribed
Supply
Vial, syringes, alcohol wipes, and cold-pack shipping
Cadence
Once-weekly subcutaneous injection
Dose decisions
Hold, change, switch, or stop based on response and tolerability
Starting price
From $199.99/mo
How it works
From questionnaire to first dose in about a week.
01
02
03
04
Start with appetite
Share cravings, portion control, weight goals, prior GLP-1 use, dose history, current medications, and weekly-injection preference.
Check risk factors
The online visit covers contraindications, blood-sugar history, GI side effects, pregnancy plans, anesthesia timing, and medication interactions before any prescription decision.
Ships cold in an insulated pack
If approved, vials, syringes, alcohol wipes, and dosing guidance ship together in one cold-pack delivery.
Adjust if needed
Dose weekly at home; message the care team if appetite, weight trend, nausea, reflux, constipation, or dose confusion changes.
Compare
1 mg starting dose vs. label titration.
REBODY
Microdose
TYPICAL
Standard titration
OTC
Supplements
Starting dose
1 mg once weekly
2.5 mg branded label start
No tirzepatide
Dose changes
Based on appetite, side effects, and dose history
Label titration schedule
No Rx dose
What you compare
Tolerance, prior GLP-1 use, price, and weekly injection cadence
Brand access, coverage, and standard escalation
Supplement claims and ingredient lists
Monthly cost
from $199.99
$250–500
$30–80
Rx
Rx only
Tirzepatide is a prescription medication, not a checkout-only weight-loss product.
Dose discipline
Your Rx sets the syringe units; no public titration chart to guess from.
Your answers stay private
Your information is encrypted and handled with care.
No guarantees
No outcome promises — appetite response and weight trend decide the next dose.
Safety & eligibility
A lower starting dose does not skip the safety review.
A lower starting dose can change tolerance, but it does not remove GLP-1 risks. Medication history, blood-sugar history, pregnancy plans, and GI side effects still matter.
Medication history comes first
Current medications, diabetes history, prior GLP-1 dose, GI history, and contraindications can all change whether tirzepatide makes sense.
Lower dose does not mean no risk
Nausea, reflux, constipation, dehydration, gallbladder issues, and rare serious reactions can still happen at lower starting doses.
Not for pregnancy or one-size-fits-all dosing
Pregnancy plans, breastfeeding, anesthesia timing, and dose tolerance can change whether a weekly injectable GLP-1/GIP belongs in the plan.
Important safety information
Review GLP‑1 risks before starting tirzepatide.
Boxed warning, contraindications, serious side effects, medication history, pregnancy, breastfeeding, gallbladder, pancreas, kidney, and anesthesia considerations can all change whether GLP-1 care should move forward.
Start with the dose question.
Share your appetite goals, prior GLP-1 use, current medications, side-effect history, and budget so the next step is not copied from a public dosing chart.
1mgStart
?Check
RxDecide
Start your online visit from$299.99/mo$199.99/mo
Split your payment into interest-free installments with Klarna at checkout.